Herwig Van Marck

1.1k total citations
29 papers, 657 citations indexed

About

Herwig Van Marck is a scholar working on Virology, Infectious Diseases and Electrical and Electronic Engineering. According to data from OpenAlex, Herwig Van Marck has authored 29 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Infectious Diseases and 11 papers in Electrical and Electronic Engineering. Recurrent topics in Herwig Van Marck's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and VLSI and FPGA Design Techniques (7 papers). Herwig Van Marck is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and VLSI and FPGA Design Techniques (7 papers). Herwig Van Marck collaborates with scholars based in Belgium, United States and Netherlands. Herwig Van Marck's co-authors include Jan Van Campenhout, Ina Vandenbroucke, Dirk Stroobandt, Gastón Picchio, Marie‐Pierre de Béthune, Tony Vangeneugden, Éric Lefebvre, Sandra De Meyer, Els De Paepe and Ben Van Baelen and has published in prestigious journals such as Gastroenterology, Trends in Ecology & Evolution and Journal of Virology.

In The Last Decade

Herwig Van Marck

29 papers receiving 648 citations

Peers

Countries citing papers authored by Herwig Van Marck

Since Specialization

Citations

This map shows the geographic impact of Herwig Van Marck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herwig Van Marck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herwig Van Marck more than expected).

Fields of papers citing papers by Herwig Van Marck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herwig Van Marck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herwig Van Marck. The network helps show where Herwig Van Marck may publish in the future.

Co-authorship network of co-authors of Herwig Van Marck

This figure shows the co-authorship network connecting the top 25 collaborators of Herwig Van Marck. A scholar is included among the top collaborators of Herwig Van Marck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herwig Van Marck. Herwig Van Marck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Study of Genotypic and Phenotypic HIV-1 Dynamics of Integrase Mutations During Raltegravir Treatment: A Refined Analysis by Ultra-Deep 454 Pyrosequencing 2012 ·The Journal of Infectious Diseases ·Daniele Armenia, Ina Vandenbroucke, Lavinia Fabeni, Herwig Van Marck, Valeria Cento, Roberta D’Arrigo, Liesbeth Van Wesenbeeck, Fernanda Scopelliti, Valeria Micheli, Bianca Bruzzone, Sergio Lo Caputo, Jeroen Aerssens, Giuliano Rizzardini, Valerio Tozzi, Pasquale Narciso, Andrea Antinori, Lieven Stuyver, Carlo Federico Perno, Francesca Ceccherini‐Silberstein	46
2	Efficacy of Re-treatment With TMC435 as Combination Therapy in Hepatitis C Virus–Infected Patients Following TMC435 Monotherapy 2012 ·Gastroenterology ·Oliver Lenz, Joep de Bruijne, Leen Vijgen, Thierry Verbinnen, Christine J. Weegink, Herwig Van Marck, Ina Vandenbroucke, Monika Peeters, Kenneth Simmen, (unknown), René Verloes, Gastón Picchio, Hendrik W. Reesink	31
3	HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 2011 ·Antiviral Research ·Valentina Svicher, E Balestra, Valeria Cento, Loredana Sarmati, Luca Dori, Ina Vandenbroucke, Roberta D’Arrigo, Anna Rita Buonomini, Herwig Van Marck, Matteo Surdo, (unknown), Wendy Mostmans, Jeroen Aerssens, Stefano Aquaro, Lieven Stuyver, Massimo Andreoni, Francesca Ceccherini‐Silberstein, Carlo Federico Perno	26
4	TMC310911, a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, Shows In Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors 2011 ·Antimicrobial Agents and Chemotherapy ·Inge Dierynck, Herwig Van Marck, Marcia Van Ginderen, Tim H. M. Jonckers, M.N.L. Nalam, Celia A. Schiffer, Araz Raoof, Guenter Kraus, Gastón Picchio	28
5	HIV-1 nucleotide mixture detection in the virco®TYPE HIV-1 genotyping assay: A comparison between Sanger sequencing and 454 pyrosequencing 2011 ·Journal of Virological Methods ·Hans Wolf, Herwig Van Marck, Wendy Mostmans, Kim Thys, Ina Vandenbroucke, Veerle Van Eygen, Theresa Pattery, Peter Verhasselt, Jeroen Aerssens	11
6	1221 TREATMENT OUTCOME AND RESISTANCE ANALYSIS IN HCV GENOTYPE 1 PATIENTS PREVIOUSLY EXPOSED TO TMC435 MONOTHERAPY AND RE-TREATED WITH TMC435 IN COMBINATION WITH PEGIFNα-2A/RIBAVIRIN 2011 ·Journal of Hepatology ·Oliver Lenz, Joep de Bruijne, Leen Vijgen, Thierry Verbinnen, Christine J. Weegink, Herwig Van Marck, Ina Vandenbroucke, Marc Peeters, Goedele De Smedt, Kenneth Simmen, (unknown), Gastón Picchio, H.W. Reesink	7
7	Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment 2010 ·Journal of Antimicrobial Chemotherapy ·Linos Vandekerckhove, Chris Verhofstede, Els Demecheleer, Stéphane De Wit, Éric Florence, Katrien Fransen, Michel Moutschen, Wendy Mostmans, Kabamba Kabeya, N Mackie, Jean Plum, D. Vaira, Karen Van Baelen, Ina Vandenbroucke, Veerle Van Eygen, Herwig Van Marck, Dirk Vogelaers, Anna María Geretti, Lieven Stuyver	21
8	HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays 2010 ·AIDS Research and Therapy ·Ina Vandenbroucke, Herwig Van Marck, Wendy Mostmans, Veerle Van Eygen, Evelien Rondelez, Kim Thys, Kurt Van Baelen, Katrien Fransen, Dolorès Vaira, Kabamba Kabeya, Stéphane De Wit, Éric Florence, Michel Moutschen, Linos Vandekerckhove, Chris Verhofstede, Lieven Stuyver	32
9	Comparison of population and 454 genotyping and Trofile phenotyping for tropism determination in patients selected for maraviroc initiation 2009 ·Ghent University Academic Bibliography (Ghent University) ·Linos Vandekerckhove, Chris Verhofstede, Ina Vandenbroucke, (unknown), Herwig Van Marck, Anna María Geretti, Lieven Stuyver	1
10	The Impact of Individual Human Immunodeficiency Virus Type 1 Protease Mutations on Drug Susceptibility Is Highly Influenced by Complex Interactions with the Background Protease Sequence 2009 ·Journal of Virology ·Herwig Van Marck, Inge Dierynck, Guenter Kraus, Sabine Hallenberger, Theresa Pattery, Gaëtan Muyldermans, (unknown), (unknown), (unknown), (unknown), E Shaw, (unknown), Cristina Martínez, (unknown), (unknown), (unknown), (unknown), Kurt Hertogs	17
11	Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials 2008 ·AIDS Research and Human Retroviruses ·Sandra De Meyer, Tony Vangeneugden, Ben Van Baelen, Els De Paepe, Herwig Van Marck, Gastón Picchio, Éric Lefebvre, Marie‐Pierre de Béthune	121
12	Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action 2006 ·Journal of Virology ·Dirk Jochmans, Jérôme Deval, Bart Kesteleyn, Herwig Van Marck, (unknown), (unknown), Pascale Dehertogh, Tania Ivens, Marcia Van Ginderen, (unknown), Maryam Ehteshami, Piet Wigerinck, Matthias Götte, Kurt Hertogs	77
13	Application of multiple linear regression modelling to the quantitative prediction of HIV-1 drug susceptibility phenotype from viral genotype 2004 ·Antiviral Therapy ·Hans Vermeiren, Tim Van den Bulcke, Herwig Van Marck, Pierre Lecocq, Margriet Van Houtte, Lee T. Bacheler	2
14	Quantitative prediction of HIV drug susceptibility from viral genotype through linear regression modelling 2003 ·Antiviral Therapy ·Herwig Van Marck, Tim Van den Bulcke, Margriet Van Houtte, Pierre Lecocq, Lee T. Bacheler	2
15	Efficient representation of interconnection length distributions using generating polynomials 2000 ·Dirk Stroobandt, Herwig Van Marck	15
16	Optoelectronic FPGAs 1999 ·IEEE Journal of Selected Topics in Quantum Electronics ·Jan Van Campenhout, Herwig Van Marck, (unknown), Joni Dambre	22
17	GART (abstract) 1998 ·(unknown), Herwig Van Marck, Jan Van Campenhout	2
18	Estimating Logic Cell to I/O Pad Lengths in Computer Systems 1997 ·Ghent University Academic Bibliography (Ghent University) ·Dirk Stroobandt, Herwig Van Marck, Jan Van Campenhout	4
19	Towards an Extension of Rent's Rule for Describing Local Variations in Interconnection Complexity 1995 ·Ghent University Academic Bibliography (Ghent University) ·Herwig Van Marck, Dirk Stroobandt, Jan Van Campenhout	26
20	Interconnection length distributions in 3-dimensional anisotropic systems 1995 ·Trends in Ecology & Evolution ·Herwig Van Marck, Dirk Stroobandt, Jan Van Campenhout	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact